A. Biber

发表

Influence of the Ginkgo extract EGb 761 on rat liver cytochrome P450 and steroid metabolism and excretion in rats and man

M. Nöldner, E. Koch, S. Chatterjee, 2005, The Journal of pharmacy and pharmacology.

Determination of nicotine and cotinine in human serum and urine: an interlaboratory study.

J. Haddow, G. Knight, G. Scherer, 1987, Toxicology letters.

Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers.

L. Jarczyk, G. Scherer, W. Heller, 1988, Klinische Wochenschrift.

KA 672‐HCl, a Neuronal Activator Against Dementia: Tolerability, Safety, and Preliminary Pharmacokinetics after Single and Multiple Oral Doses in Healthy Male and Female Volunteers

R. Hoerr, H. Derendorf, H. Sourgens, 1998, Journal of clinical pharmacology.

Enzymatic Cleavage of Thymopoietin Oligopeptides by Pancreatic and Intestinal Brush-Border Enzymes

S. Wolffram, P. Langguth, H. Merkle, 1996, Peptides.

Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers

S. Chatterjee, H. Fischer, A. Römer, 1998, Pharmacopsychiatry.

[Pharmaokinetics of beta-escin after administration of various Aesculus extract containing formulations].

A. Biber, R. Oschmann, K. Kunz, 1996, Die Pharmazie.

Antiviral and antiphlogistic activities of Hamamelis virginiana bark.

H. Rabenau, J. Činátl, H. Doerr, 1996, Planta medica.

Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.

E. Koch, A. Biber, 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations

B. Schug, H. Blume, S. Kressmann, 2002, The Journal of pharmacy and pharmacology.

Pharmacokinetics of [14C]-labelled losigamone and enantiomers after oral administration to healthy subjects

J. Wieling, J. Jonkman, P. Peeters, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Pharmacokinetics of losigamone, a new antiepileptic drug, in healthy male volunteers.

A. Dienel, A. Biber, 1996, International journal of clinical pharmacology and therapeutics.

Bioavailability of Ginkgolides and Bilobalide from Extracts of Ginkgo biloba using GC/MS

E. Koch, A. Biber, 1999, Planta medica.

[Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].

J. Fourtillan, A. M. Brisson, I. Ingrand, 1995, Therapie.

Stimulation of Glutamate, Aspartate and Gamma-Aminobutyric Acid Release from Synaptosomes by Hyperforin

S. Chatterjee, A. Biber, S. Chaterjee, 2001, Pharmacopsychiatry.

Local cerebral glucose utilization of the awake rat during chronic administration of nicotine

W. Kuschinsky, F. Grünwald, H. Schröck, 1988, Brain Research.

Urinary mutagenicity after controlled exposure to environmental tobacco smoke (ETS).

G. Scherer, F. Adlkofer, A. Biber, 1987, Toxicology letters.

Pharmacokinetics of Ginkgo biloba Extracts

A. Biber, 2003, Pharmacopsychiatry.